Patent 10251895 was granted and assigned to Valeant Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.
Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.